Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex
- 1 September 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (6) , 418-421
- https://doi.org/10.1016/0002-9149(86)90006-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Intravenous urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1985
- Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiographyThe American Journal of Cardiology, 1985
- Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.Circulation, 1985
- Prevention of Myocardial Infarction by Very Early Treatment with Intracoronary StreptokinaseNew England Journal of Medicine, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studiesThe American Journal of Cardiology, 1984
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980